{"id":7028,"date":"2015-06-16T21:03:05","date_gmt":"2015-06-17T01:03:05","guid":{"rendered":"https:\/\/cyclecapital.creatures.ca\/2015\/06\/16\/293\/"},"modified":"2015-06-16T21:03:05","modified_gmt":"2015-06-17T01:03:05","slug":"293","status":"publish","type":"post","link":"https:\/\/cyclecapital.com\/en\/2015\/06\/16\/293\/","title":{"rendered":"Inocucor Technologies Opens New Lab and Corporate Headquarters, Marks Growth Milestones"},"content":{"rendered":"
\n

Montreal, June 18, 2015\u00a0 \u2013 Inocucor Technologies Inc. Ltd,\u00a0the agriculture biotech company that produces sustainable biological accelerators for farmers, today opened its new 10,000-square-foot corporate headquarters at 7220 Frederick-Banting in Technoparc Montreal.<\/p>\n

Inocucor<\/a> is a leading innovator and producer of bio-based products that improve crop yields, shorten growing periods and create healthier, more resilient soils for organic farmers, greenhouse growers and mainstream production farmers.<\/p>\n

Its new facility was designed to be compliant with current Good Manufacturing Practices (cGMPs) for the food industry. It serves as the company\u2019s headquarters, R & D and pilot production laboratories for its next-generation bio-stimulation products for production agriculture, which have attracted collaborators from both the private and academic sectors in Canada and the U.S.<\/p>\n

Speaking at the company\u2019s official opening today, Inocucor\u2019s President and CEO Donald R. Marvin commented on the company\u2019s progress in the two years since it introduced Inocucor Garden SolutionTM, which is OMRI Listed\u00ae for organic production, approved in 27 U.S. states and generating revenues from greenhouse growers and farmers in the Carolinas, Florida, Georgia and Virginia.<\/p>\n

\u201cThe inauguration of this beautiful, state-of-the-art facility gives Inocucor a launching pad from which to develop and introduce first-in-class sustainable bio-stimulant and bio-protectant products that enable plants to grow more vigorously and increase their ability to fight disease,\u201d he said.<\/p>\n

\u201cOur plans and pipeline for new products are ambitious. But they\u2019re attainable, because our technology solution is unique in the agricultural biologicals sector. Its efficacy is being proven every day in farmers\u2019 fields, and in test labs and greenhouses at respected research institutions such as McGill University.\u201d<\/p>\n

Inocucor\u2019s core technology was developed in 2007 by two Montreal scientists, Dr. Margaret Bywater\u2013Ekeg\u00e4rd and Ananda Lynn Fitzsimmons, who believed that microbial, rather than chemical, solutions would be needed to help famers feed a growing world population. They use a proprietary fermentation process akin to winemaking to brew natural bacteria and yeasts into powerful growth stimulants for soil, seeds and plants.<\/p>\n

\u201cWe are very pleased to have Inocucor Technologies among the companies prospering here in Saint-Laurent,\u201d announced Saint-Laurent Mayor Alan DeSousa. \u201cTheir work in developing sustainable biological products corresponds with a positive vision combining prosperity and respect for the environment which is in keeping with the values of Saint-Laurent\u2019s Administration. Moreover, with its 4600 companies and its four major industrial clusters, Saint-Laurent offers an environment that is conducive to business development, through its geographic location in the heart of the island of Montr\u00e9al and its research and development vitality.\u201d<\/p>\n

Inocucor has attracted two rounds of venture capital from Cycle Capital Management, a respected Canadian venture capital firm focused on the clean-tech sector. In early February, 2015, Inocucor closed an interim round of financing from Cycle Capital Management with participation from Desjardins-Innovatech, the venture capital unit of one of North America\u2019s leading financial institutions.<\/p>\n

The company recently launched its Series B equity financing, on the order of $15 million, and expects its completion during the second half of 2015.<\/p>\n

In the past six months, Inocucor has added nearly a dozen scientific, operations and sales professionals. Marvin estimates Inocucor will grow to 35 employees by early 2016. Inocucor has co-product development partnerships underway with Axter Agrosciences Inc., one of Canada\u2019s leading providers of foliar feeding crop solutions, and with McGill University\u2019s Department of Plant Sciences.<\/p>\n

In Canada, Inocucor has a number of field trials underway to test its second-generation product with soybeans and corn. In the U.S. Southeast, it is managing nearly 100 ongoing field demonstrations for tomatoes, strawberries, watermelons, broccoli and other high-value produce. It has just begun to work with farmers in Iowa and Illinois to test its biologicals on more than 100 acres of corn and soybeans.<\/p>\n

In its first two years of field trials for row crops at McGill University, Inocucor\u2019s second-generation bio-stimulant product for large-scale agriculture produced yield increases of at least 10 percent. In a 2014 trial with Packman Broccoli by Clemson University\u2019s Sustainable Agriculture Program, plants treated with Inocucor\u2019s Garden Solution, out-yielded untreated broccoli by 38 percent. Recent trials can be viewed at http:\/\/inocucor.com\/science\/field-studies<\/p>\n

Internationally recognized McGill University plant scientist Donald L. Smith heads Inocucor\u2019s Scientific Advisory Board. The company has also attracted two North American agriculture luminaries to its board of directors: Jim Blome, President & CEO of Bayer CropScience L.P. and Head of Crop Protection for its North American region, and Dr. Ted Crosbie, one of the world\u2019s top figures in agronomic research and development who managed Monsanto\u2019s Global Plant Breeding and Global Wheat Breeding businesses from 1996 to 2014.<\/p>\n<\/div>\n

About Inocucor Technologies Inc.<\/h2>\n

Inocucor Technologies Inc., based in Montreal, is an ag biotech company that develops sustainable biological products for agriculture targeting the phyto-microbiome\u2014the seeds, plants, root systems and the soil surrounding them. Inocucor\u2019s first-generation product, Garden Solution\u2122, employs live microbes to actively improve the health of the entire phyto-microbiome. Future generations of Inocucor products are powerful cell-free biological solutions for bio-stimulation and bio-protection in mainstream production agriculture. For more information, please visit www.inocucor.com<\/a>.<\/p>\n

Media Contact:<\/h3>\n

Michele Wells<\/p>\n

Wells Communications (303) 417-0696<\/p>\n

mwells@wellscommunications.net<\/a><\/p>\n

 <\/p>\n

Get the PDF version of the release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Montreal, June 18, 2015\u00a0 \u2013 Inocucor Technologies Inc. Ltd,\u00a0the agriculture biotech company that produces sustainable biological accelerators for farmers, today opened its new 10,000-square-foot corporate headquarters at 7220 Frederick-Banting in Technoparc Montreal. Inocucor is a leading innovator and producer of bio-based products that improve crop yields, shorten growing periods and create healthier, more resilient soils […]<\/p>\n","protected":false},"author":1,"featured_media":6821,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7028","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/posts\/7028","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/comments?post=7028"}],"version-history":[{"count":0,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/posts\/7028\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/media\/6821"}],"wp:attachment":[{"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/media?parent=7028"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/categories?post=7028"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cyclecapital.com\/en\/wp-json\/wp\/v2\/tags?post=7028"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}